Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J. 2010 Oct;10(5):375-84. Epub 2009 Dec 22 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Honolulu: Tomm40 Reported to Track With Brain Atrophy, Cognition
  2. Genetics of FTD: New Gene, PGRN Variety, and a Bit of FUS
  3. Bethesda: Dawn of the Epigenetics Era
  4. Toronto: Human Amyloid Imaging Conference Showcases a Maturing Field
  5. Large Study Questions Tomm40’s Effect on AD Age of Onset
  6. ApoE2 Carriers Have Less Brain Atrophy, AD Pathology in Spinal Fluid
  7. From Shared CAP, Secondary Prevention Trials Are Off and Running
  8. There’s No Tomorrow for TOMMORROW

Mutations

  1. APOE Region